Currently, the management of advanced pancreatic cancer patients is complex in second-line chemotherapy according to the absence of clear recommendations. Better discrimination for the prediction of overall survival (OS) at the beginning of second-line chemotherapy is needed to clarify and improve therapeutic decisions. Here, we proposed a prognostic nomogram and score to address this issue.
Prediction tools are designed to help physicians to predict patient’s risk profile and individual prognosis that may help to guide clinical management. They may also be used by researchers to optimize the design of future clinical trials and thus to ensure well-balanced arms for risk profile.
If you are a patient, we recommend that you use these tools only in consultation with your healthcare provider.
About Dewi VERNEREY
Dewi Vernerey is a research engineer in epidemiology and biostatistics who received a master’s degree cum laude from Joseph Fourier University (Grenoble, France) with a major in engineering statistics. He defended a PhD in epidemiology and statistics in 2016. His PhD research focused on statistical methodology for risk prediction and prognostic score construction in oncology and kidney transplantation.